Zoetis Inc Class A Common Stoc (ZTS) 51.26 $ZTS Blog

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Zoetis Inc Class A Common Stoc (ZTS) 51.26 $ZTS

Blog Coverage Valeant Pharma Appoints New CEO
ACCESSWIRE - Tue Aug 23, 8:15AM CDT
LONDON, UK / ACCESSWIRE / August 23, 2016 / Active Wall St. blog coverage looks at the headlines from Valeant Pharmaceuticals International, Inc. (NYSE: VRX) and Zoetis Inc. (NYSE: ZTS). Zoetis announced on August 21, 2016, that it had appointed Glenn David as its Executive Vice President and Chief Financial Officer (CFO). The announcement came in the wake of the resignation of Executive Vice President and CFO Paul S. Herendeen on August 18, 2016. On August, 22, 2016, Valeant Pharmaceuticals International, Inc. (NYSE: VRX) announced the appointment of Paul S. Herendeen to take on the role of CFO from Robert L. Rosiello. Register with us now for your free membership and blog access at: http://www.activewallst.com/register/.
AGN: 235.96 (-1.80), ZTS: 51.26 (+0.15), VRX: 28.76 (-0.36), TROW: 69.27 (+0.52), VRX.TO: 37.34 (-0.75)

Eli Lilly, AstraZeneca Alzheimer's Drug Gets FDA Fast Track
Arpita Dutt - Zacks Investment Research - Tue Aug 23, 7:59AM CDT
Eli Lilly (LLY) and AstraZeneca's (AZN) Alzheimer's disease treatment is currently in phase III studies.
ZTS: 51.26 (+0.15), AZN: 33.31 (+0.71), LLY: 76.85 (-0.38)

Veterinary Vaccines Market is Expected to Rise to US$11,403.6 mn by 2024; Rising Expenditure on Animal Healthcare by Pet Owners and Livestock Farmers to Drive Market Globally, Reports TMR
PR Newswire Europe - Tue Aug 23, 6:31AM CDT
ALBANY, New York, August 23, 2016 /PRNewswire/ --
ZTS: 51.26 (+0.15), MRK: 62.98 (+0.08)

Zacks.com featured highlights: Macy's, Discovery Communications, Zoetis, Boston Scientific and Priceline Group
Zacks Equity Research - Zacks Investment Research - Mon Aug 22, 8:30AM CDT
Zacks.com featured highlights: Macy's, Discovery Communications, Zoetis, Boston Scientific and Priceline Group
BSX: 24.26 (-0.07), ZTS: 51.26 (+0.15), DISCK: 25.08 (+0.13), M: 36.64 (+0.30), PCLN: 1,422.85 (+4.26)

Zoetis Announces Appointment of Glenn David as Executive Vice President and Chief Financial Officer
BusinessWire - Sun Aug 21, 8:13PM CDT
Zoetis Inc. (NYSE:ZTS) today announced that Glenn David, Senior Vice President of Finance Operations, has been named Executive Vice President and Chief Financial Officer (CFO), and will assume responsibility for the oversight of the company's financial management, planning and global operations, effective immediately. As CFO, David will report directly to Chief Executive Officer Juan Ramon Alaix and become part of the Zoetis Executive Team. David will succeed Executive Vice President and Chief Financial Officer Paul Herendeen, who has resigned effective August 18, 2016, to accept the position of CFO at another public company.
ZTS: 51.26 (+0.15)

Top Research Reports for August 19, 2016
Sheraz Mian - Zacks Investment Research - Fri Aug 19, 10:44AM CDT
Top Research Reports for August 19, 2016
ZTS: 51.26 (+0.15), AVB: 175.46 (-0.35), LOW: 76.96 (+0.52), TEVA: 51.22 (+0.32), CMCSA: 66.16 (+0.27), VZ: 52.88 (+0.32)

5 Top ROE Stocks to Play in an Aging Bull Market
Supriyo Bose - Zacks Investment Research - Fri Aug 19, 7:05AM CDT
As investors scout for cherry pickings in an aging bull market, they are often on the lookout for "cash cow" stocks that would enable them to milk more cash or profits.
ZTS: 51.26 (+0.15), BSX: 24.26 (-0.07), DISCK: 25.08 (+0.13), M: 36.64 (+0.30), PCLN: 1,422.85 (+4.26)

Zoetis to Participate in the Morgan Stanley Global Healthcare Conference
BusinessWire - Thu Aug 11, 7:30AM CDT
Zoetis Inc.(NYSE:ZTS) will participate in the Morgan Stanley Global Healthcare Conference on Wednesday, Sept. 14, 2016, in New York, N.Y. Juan Ramon Alaix, Chief Executive Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 10:30 a.m. EDT.
ZTS: 51.26 (+0.15), MS: 31.89 (-0.02)

Zoetis Acquires Scandinavian Micro Biodevices to Extend Its Pipeline in Diagnostics for Veterinary Use
BusinessWire - Mon Aug 08, 7:00AM CDT
--Adds to diagnostics portfolio with specialty test instruments and cartridges
ZTS: 51.26 (+0.15)

Zacks.com featured highlights: Macy's, General Mills, Zoetis, Boston Scientific and Citrix Systems
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 8:30AM CDT
Zacks.com featured highlights: Macy's, General Mills, Zoetis, Boston Scientific and Citrix Systems
BSX: 24.26 (-0.07), ZTS: 51.26 (+0.15), M: 36.64 (+0.30), GIS: 70.94 (+0.83), CTXS: 86.98 (-0.30)

Zoetis (ZTS) Beats on Q2 Earnings & Revenues, Lifts Outlook
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 9:52AM CDT
Zoetis (ZTS) reported better-than-expected second-quarter 2016 earnings of 49 cents per share.
ZTS: 51.26 (+0.15), FCSC: 0.89 (-0.01), ANIP: 59.86 (-1.56), ANIK: 47.89 (-0.05)

Prothena (PRTA) Reports Wider-than-Anticipated Loss in Q2
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 9:45AM CDT
Prothena (PRTA) reported a wider-than-expected loss of $1.18 per share in the second quarter of 2016.
ZTS: 51.26 (+0.15), ANIP: 59.86 (-1.56), PRTA: 52.19 (-0.02)

Zoetis (ZTS) Tops Q2 Earnings, Revenue Estimates
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 8:19AM CDT
Zoetis (ZTS) beat both top- and bottom-line estimates in the second quarter of 2016.
ZTS: 51.26 (+0.15)

5 Top ROE Stocks to Buy as Earnings Growth Remains Elusive
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 7:57AM CDT
A high ROE ensures that the company is reinvesting its cash at a high rate of return.
ZTS: 51.26 (+0.15), BSX: 24.26 (-0.07), M: 36.64 (+0.30), GIS: 70.94 (+0.83), CTXS: 86.98 (-0.30)

Zoetis Reports Second Quarter 2016 Results
BusinessWire - Wed Aug 03, 6:00AM CDT
--Zoetis Reports Adjusted Net Income of $246 Million, or Adjusted Diluted EPS of $0.49, for Second Quarter 2016
ZTS: 51.26 (+0.15)

Drug Stocks to Watch for Earnings on Aug 3: ZTS, EXEL & More
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 9:30AM CDT
Can drug stocks Zoetis, Conatus and others pull a surprise when they report their Q2 results on Aug 3?
ZTS: 51.26 (+0.15), JNJ: 119.32 (+0.24), GILD: 76.89 (-0.53), GERN: 2.75 (+0.02), CNAT: 1.84 (-0.02), AERI: 19.60 (+0.39), EXEL: 11.54 (+0.19)

Keryx (KERX) Stock Down on Wider Q2 Loss, Supply Issues
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 8:17AM CDT
Keryx (KERX) announced disruption in the supply of Auryxia tablets along with disappointing second-quarter results.
ZTS: 51.26 (+0.15), INVA: 11.09 (+0.02), ANIP: 59.86 (-1.56), KERX: 4.15 (+0.02)

Sanofi (SNY) Posts In-Line Q2 Earnings, Revenues Down Y/Y
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 4:19PM CDT
Sanofi (SNY) reported second-quarter 2016 business earnings of 74 cents per American Depositary Share, in line with the Zacks Consensus Estimate.
ZTS: 51.26 (+0.15), INVA: 11.09 (+0.02), ANIP: 59.86 (-1.56), SNY: 39.18 (+0.77)

Zoetis (ZTS): Stock to Beat Earnings Estimates in Q2 Again
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 11:01AM CDT
Zoetis (ZTS), which is set to report second-quarter 2016 results on Aug 3, had delivered a positive earnings surprise of 17.07% last quarter.
ZTS: 51.26 (+0.15), ABT: 42.09 (-0.21), ICPT: 150.74 (+3.92), EXEL: 11.54 (+0.19)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mike Blyth’s Hall of Fame Honors a Builder’s Legacy

Updated Category News Views 147

Recognition earned in the hangar, not a boardroom Aircraft design has a ruthless way of exposing empty talk, which is why Mike Blyth’s November 11 induction into the EAA Homebuilders Hall of Fame carries real weight. The Experimental Aircraft Association’s honor, presented in the Eagle Hangar at the EAA Aviation Museum in Oshkosh, Wisconsin, recognizes a career built...

Continue Reading
LASIK Cost Math Deserves a Careful Second Look Today

Updated Category News Views 114

Thirty years of lens purchases can become a nasty tab Contact-lens spending has a funny way of staying invisible until somebody stacks the receipts into one ugly pile. A new cost-of-vision analysis from the surgeon advisory board of BestLASIKSurgeons.com says the average American contact-lens wearer may spend between $22,500 and $30,000 on corrective eyewear across 30...

Continue Reading
SanMar’s Lott Tops Promo Products Power 50 Again in 2026

Updated Category News Views 102

Branded hoodies and logo tumblers rarely make Wall Street’s pulse race, but the numbers behind them deserve a hard look. Jeremy Lott, president and CEO of SanMar, was named the most influential leader in the U.S. promotional-products business for the second consecutive year, taking No. 1 in the 2026 Counselor Power 50 ranking. Awards can be fluff. A repeat win beside...

Continue Reading
Onward Therapeutics Secures $28M to Bolster Oncology R&D

Updated Category News Views 76

Cashing In to Conquer Cancer In the risk-laden world of biotech, Onward Therapeutics has just bagged a hefty NT$900 million—roughly US$28 million—from its Series B financing. That's not pocket change and speaks to the level of confidence their backers have, even as they plant their global headquarters firmly in Taipei since relocating from Switzerland. A Deep Dive...

Continue Reading
Docusign Pushes Contract Data Into ChatGPT Sales Tools

Updated Category News Views 179

Contracts are where sales momentum goes to get lost, buried under old PDFs, approval chains, and somebody’s half-finished CRM note. Docusign’s November 17, 2026 launch is a sensible attempt to drag that information into the place sellers may increasingly spend their working day: ChatGPT for Sales. The company’s new plugin lets a sales rep pull agreement intelligence...

Continue Reading
MacDill Mold Case Puts Privatized Housing on Notice

Updated Category News Views 38

Four hundred fifty-four people are a hard number to shrug off. The expanded civil case over alleged toxic mold conditions at MacDill Air Force Base now covers 105 military families, up from 39 households when it was filed in September 2025. Their complaint against The Michaels Organization and affiliated entities may be the largest known military-housing lawsuit in the...

Continue Reading
Toledo Crosswalk Death Lawsuit Raises Hard Questions

Updated Category News Views 237

A painted crosswalk is supposed to mean something, and that is the grim center of the lawsuit filed over Judy Tanner’s death in Toledo. Tanner, 20, was walking home from work on September 10, 2026, when she was struck and killed while crossing the street. Her estate is now suing, alleging that the 31-year-old driver failed to yield as Tanner legally used the crosswalk....

Continue Reading
Concierto's Azure Push Puts Sovereignty on Display

Updated Category News Views 78

Sovereignty has become the corporate cloud world's favorite hard-edged word. Concierto is taking that word straight onto the Microsoft Ignite 2026 floor, and frankly, it is a sensible place to make the case. The company, part of Trianz, will appear as a Gamechanger Sponsor from November 17 through 20 at San Francisco's Moscone Center, showing its platform at Booth #5435....

Continue Reading
Max y Noelia Explore Trade at 9th CIIE in Shanghai

Updated Category News Views 60

Influencers at the Heart of Global Trade Exploration Makin' their debut on the big stage of the 9th China International Import Expo (CIIE), Mexican influencers Max y Noelia found themselves caught in a whirlwind of trade and cultural exchanges over in Shanghai. These digital mavens aren't just snapping selfies. Nope, they're capturing the very essence of international...

Continue Reading
Red Cat Stock Drama: Revenue Targets and Legal Waves

Updated Category News Views 110

Red Cat's Revenue Predictions Crash and Burn Sitting there on August 6, 2026, Red Cat Holdings had everyone believing they were on a fast track to hitting a hefty revenue target: $150–$180 million for FY2026. CEO Jeffrey Thompson didn't mince words, boasting confidence like a captain before a storm. Fast forward three months, and they're waving the white flag, tossing...

Continue Reading

Top 5 Most Recently Viewed Articles

B. Riley Financial Partners with Oaktree to Enhance Services

Updated Category News Views 55

B. Riley Financial and Oaktree: A Strategic Collaboration B. Riley Financial, Inc. (NASDAQ: RILY) is thrilled to announce a new partnership with Oaktree Capital Management, L.P. to strengthen its Great American Group businesses. Definitive Agreement Signed The companies have finalized a definitive agreement enabling a collaboration through a newly formed holding company...

Continue Reading
General Motors Faces Changes: A Shift in EV Incentive Strategy

Updated Category News Views 348

General Motors Adjusts EV Incentives General Motors Co. (NYSE: GM) has decided to revise its plans concerning electric vehicle (EV) incentives after initially suggesting options beyond the Federal EV Credit deadline. This shift comes shortly after rising scrutiny from political figures around the implications of such financial strategies. Concerns Raised by Key...

Continue Reading
Pacsun Unveils Stylish New Sunglasses Collection for All

Updated Category News Views 327

Pacsun Launches an Elegant Sunglass Collection Pacsun has taken a bold step in expanding its product range by introducing a new collection of premium sunglasses. This unisex line represents the brand's commitment to elevating its accessory offerings, appealing to a broader audience of style-conscious consumers. Innovative Designs in Sunglass Fashion With the release of...

Continue Reading
Exploring the Rapid Growth of the Opioid Use Disorder Market

Updated Category News Views 216

Understanding the Opioid Use Disorder Market and Its Promising Growth The opioid crisis represents a major public health challenge, significantly impacting communities across the globe. According to research, the Opioid Use Disorder Market was evaluated at approximately USD 3.7 billion recently, with an exciting projection to surge to USD 9.02 billion by 2032. This...

Continue Reading
Artea Bankas Secures ECB Approval for Stock Buyback Initiative

Updated Category News Views 242

Artea Bankas Secures ECB Approval for Stock Buyback Initiative AB Artea Bankas has recently gained essential approval from the European Central Bank (ECB) allowing the bank to buy back up to 4,500,000 of its own shares, marking a significant step in enhancing shareholder value. This buyback program is anticipated to commence within one year, demonstrating the bank's...

Continue Reading